Viral Immunity: Basic Mechanisms and Therapeutic Applications

Web Desc
Viral Immunity: Basic Mechanisms and Therapeutic Applications - RESCHEDULING IN PROGRESS
joint with Respiratory Viruses: New Frontiers - RESCHEDULING IN PROGRESS
Scientific Organizers: Katherine Kedzierska and Paul G. Thomas
Date: February 05 - 09, 2021
Location: Fairmont Banff Springs, Banff, AB, Canada
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Sponsored by AstraZeneca, BioLegend, Inc. and Gilead Sciences, Inc.
For important information on the coronavirus, please click here
Summary of Meeting:
Viruses infection millions annually, causing severe illness and threatening global public health. Limiting the impact of viral infection requires a multi-layered understanding of viral immunity, from basic research on viral recognition and host immune response, to the clinical applications of novel antiviral and host-targeted therapies and vaccines. Despite recent advances, the mechanisms of both both rapid host recovery as well as severe and fatal disease outcomes, are far from clear. This Keystone Symposia conference will cover a wide range of topics in viral immunity including innate immunity and inflammation, viral sensing and antigen presentation, adaptive T and B cell immunity, novel vaccine development, human immunology across anatomical sites, and innovative computational analyses. Animal models will be examined alongside human and clinical studies, and multi-disciplinary integration will enhance perspectives. A key outcome will be fostering collaborations across different approaches such as viral models and host systems, and across different communities from academia to government to industry. The overall objective of this conference is to provide a unique opportunity for cross-disciplinary interaction and knowledge exchange. Joint efforts in understanding viral immunity are needed for the rational design and development of immunotherapies and vaccines towards seasonal, emerging, and re-emerging viruses.
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AstraZenecaBill & Melinda Gates FoundationBioLegend, Inc.Gilead Sciences, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI154971-01
Funding for this conference was made possible (in part) by 1R13AI154971-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found